IPO Issue Details
Issue Price / Price Band₹441 per share (Fixed Price)
Face Value₹2 Per Share
Lot Size34 Shares per Lot
Total Issue Size1,91,89,330 shares (aggregating up to ₹846.25 Cr)
Issue TypeBookbuilding IPO
Sale Type / CategoryOffer For Sale
Exchange / PlatformNSE & BSE
IPO TypeMainboard
Subscription OpenFri, 29 Nov 2024
Subscription CloseTue, 03 Dec 2024
Anchor AllotmentThu, 28 Nov 2024
Basis of AllotmentWed, 04 Dec 2024
Initiation of RefundsThu, 05 Dec 2024
Credit of Shares to DematThu, 05 Dec 2024
Listing DateFri, 06 Dec 2024
UPI Mandate Deadline2024-12-03
Application & Investment Details
Retail — Min (1 Lots)₹14,994 — 34 shares
Retail — Max (13 Lots)₹194,922 (13 Lots)
HNI — Min (14 Lots)₹2,09,916 — 476 shares
EPS (Pre-IPO)₹4.44
EPS (Post-IPO)₹5.89
P/E Ratio (Pre-IPO)99.31x
P/E Ratio (Post-IPO)74.89x
Pre-IPO Promoter Holding5,20,80,758 shares
Post-IPO Promoter Holding5,20,80,758 shares
About Suraksha Diagnostic Ltd.
Incorporated in 2005, Suraksha Diagnostic Limited offers pathology, radiology testing and medical consultancy services. The company has a central reference laboratory with 8 satellite laboratories and 215 customer touchpoints, including 49 diagnostic centres and 166 sample collection centres as of June 30, 2024, across West Bengal, Bihar, Assam, and Meghalaya.The company offers its customers online and offline medical consultation services under one roof via 44 diagnostic centres, which house 120 polyclinics with more than 750 doctors.The operation of the diagnostic centres is supported by the technology platforms and systems that the company uses to streamline, such as its Laboratory Information Management System ("LIMS"), its fully integrated Radiology Information System ("RIS"), its Picture Archive Communication System ("PACS") and its Enterprise Resource Planning System ("ERP").The company offers vaccination services and customized testing packages for disease prediction/early detection. The company uses digital pathology and artificial intelligence to generate blood tests. All radiology reporting is done through a digital platform that allows cases to be reported from all diagnostic centres, significantly reducing turnaround time.Competitive Strengths are:Well-positioned diagnostics chain to capture the large growth opportunities for organized diagnostics chains in the fragmented markets for diagnostic services in eastern and northeastern India.Integrated diagnostics provider offering pathology and radiology testing and medical consultancy services from a single source.Well-invested and technologically advanced clinical infrastructure.Commitment to quality driving high individual consumer business share and customer retention.Management team with relevant industry experience.
Objects of the Issue
Suraksha Diagnostic Ltd. proposes to utilise the net proceeds from the Issue for the following objects:
1
The Company will not receive any proceeds from the Offer for sale and all proceeds will go to the Selling Shareholders.
Shareholding & Lock-in
Pre-IPO Promoter Holding
5,20,80,758 shares
Post-IPO Promoter Holding
5,20,80,758 shares
Lock-in Period (30%)January 3, 2025
Lock-in Period (50%)March 4, 2025